Diabetes most prevalent in southern US

	Tweet

Diabetes prevalence is highest in the Southern and Appalachian states and lowest in the Midwest and the Northeast of America. Researchers writing in BioMed Central’s open access journal Population Health Metrics have used two public data sources to investigate the prevalence of diagnosed and undiagnosed diabetes mellitus at the State level.

Goodarz Danaei, from the Harvard School of Public Health, Boston, worked with a team of researchers to combine the data from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System. He said, “Diabetes mellitus is the sixth leading cause of death in the United States, accounting for approximately 70,000 annual deaths. To our knowledge, this is the first study to estimate what the true level of diabetes disease is in every state and how the different states perform in terms of diagnosed vs. undiagnosed diabetes”.

Age-standardized diabetes prevalence was highest in Mississippi, West Virginia, Louisiana, Texas, South Carolina, Alabama and Georgia, ranging from 15.8% to 16.6% for men and 12.4% to 14.8% for women. The lowest prevalences were found in Vermont, Minnesota, Montana, and Colorado, just 7% for women in the Northeast and some Western states. 

These results currently provide the only estimates of total diabetes and undiagnosed diabetes in U.S. states. According to Danaei, “States like Minnesota and Alabama with the highest estimated diabetes prevalence in our analysis also have the highest levels of blood pressure and cardiovascular disease risk. This concentration of cardiovascular risks and diabetes points to the need for lifestyle and health care interventions in these states”.

The researchers hope their figures will provide motivation, guidance, and benchmarks for designing, implementing, and evaluating diabetes prevention and state level control programs at the state level.

###

Notes to Editors

1. Diabetes prevalence and diagnosis in US states: analysis of health surveys
Goodarz Danaei, Ari B Friedman, Shefali Oza, Christopher JL Murray and Majid Ezzati
Population Health Metrics (in press)

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central’s open access policy.

Article citation and URL available on request at on the day of publication

2. Population Health Metrics is an Open Access, peer-reviewed, online journal addressing all aspects of measurement of the health of populations. Population Health Metrics will address issues relating to concepts, methods, ethics applications and results in the measurement of the health of populations. This will include areas of health state measurement and valuation, summary measures of level of population health, and inequality in population health, descriptive epidemiology at the population level, burden of disease and injury analysis, disease and risk factor modelling for populations, and comparative assessment of risks to health at population level. The journal aims to provide a platform for researchers in all these areas to share their findings with the global research community.

3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

Contact: Graeme Baldwin

44-203-192-2165
BioMed Central

RELATED STORIES:
Phone contact with nurses linked with better outcomes for women with gestational diabetes   Death rate drops among Americans with diabetes -CDC   Correct treatment of common diabetic foot infections can reduce amputations   “Pre-diabetes,” diabetes rising among U.S. teens   Experimental bariatric surgery controls blood sugar in rats with diabetes   53 millions Americans might develop diabetes by 2025   New inflammation hormone link may pave way to study new drugs for type 2 diabetes   Diabetic retinopathy research could reduce screening costs   Liver fat gets a wake-up call that maintains blood sugar levels   Low testosterone levels could raise diabetes risk for men   Prosthetic lets diabetic get a foot up on life   Dealing with Diabetes, One Patient at a Time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]